Variables | Zinc group | Placebo group | p-value | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Baseline | Week 15 | Mean change | Baseline | Week 15 | Mean change | P2 | P3 | P4 | P5 | |
Zinc (µg/dL)1 | 65.2 ± 5.9 | 75.4 ±  8.2 | 10.2 ±  6.8 | 71.15 ± 13.2 | 68.15 ± 10 | − 3  ± 13.1 | 0.086 | 0.018 | 0.0001 | 0.002 |
P1 | 0.0001 | 0.296 | ||||||||
hs-CRP (mg/L)1 | 5.27 ± 2.93b | 3.37 ± 2.24 | − 1.89 ± 1.60 | 4.75 ± 2.28 | 3.98 ± 2.04 | − 0.07 ± 1.8 | 0.124 | 0.064 | 0.0001 | 0.0001 |
P1 | 0.0001 | 0.60 | ||||||||
TNF-α (pg/ml) 2 | 32.41 (10.92, 708.48) a | 30.43 (11.79, 546.19) | − 1.98 | 26.07 (13.19, 67.47) | 25.07 (9.62, 94.65) | − 1.0 | 0.170 | 0.238 | 0.293 | 0.723 |
P1 | 0.473 | 0.451 | ||||||||
Apelin (pg/ml)2 | 1568.20 (1119, 3282) | 1245.13 (482, 2087) | − 323.07 | 1493.45 (505, 4467) | 1683.32 (963, 3804) | 189.87 | 0.805 | 0.017 | 0.002 | 0.001 |
P1 | 0.042 | 0.001 | ||||||||
FBS (mg/dL)1 | 86.83 ± 11.94 | 83.50 ± 7.36 | − 3.33 ± 6.56 | 86.90 ± 9.93 | 86.90 ± 13.42 | 0.00 ± 6.00 | 0.983 | 0.343 | 0.102 | 0.088 |
P1 | 0.046 | 1.00 | ||||||||
Insulin (microU/L)2 | 5.91 (1.7,18.60) | 4.05 (1,9.1) | − 1.86 | 5.07 (1.8, 22.6) | 5.08 (1.7, 27.2) | 0.01 | 0.135 | 0.33 | 0.019 | 0.073 |
P1 | 0.002 | 0.735 | ||||||||
HOMA-IR2 | 1.35 (0.37, 2.81) | 0.83 (0.21, 2.27) | − 0.52 | 1.02 (0.41, 5.88) | 1.08 (0.33, 9.27) | 0.06 | 0.160 | 0.294 | 0.011 | 0.031 |
P1 | 0.0001 | 0.757 | ||||||||
NPY (ng/l)2 | 306.1 (178.8, 1540.5) | 273.8 (170.1, 1022.8) | − 32.27 | 400.9 (198.9, 2239.2) | 411.6 (180.6, 1900.9) | 10.72 | 0.147 | 0.037 | 0.048 | 0.151 |
P1 | 0.114 | 0.243 | ||||||||
Appetite1 | 16.00 ± 2.11 | 13.77 ± 2.36 | − 2.22 ± 2.81 | 15.50 ± 1.80 | 15.45 ± 1.59 | − 0.04 ± 1.59 | 0.426 | 0.011 | 0.007 | 0.001 |
P1 | 0.004 | 0.892 |